- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06351137
Timecost of Intranasal Versus Intravenous Analgesia in Traumatic Pain
Prehospital treatment of acute traumatic pain is common in military practice. Analgesics are usually administered intravenously (IV). Research from the civil prehospital environment shows that obtaining IV access can be difficult and time consuming, delaying onset of treatment. The challenges for obtaining IV access in the military prehospital setting are even bigger, for example in combat environments. However, this has not been assessed.
Current guidelines also offer alternative routes of administration for analgesics, for example intranasal (IN) administration. IN administration is a fast, easy and effective route of administration. This study determines whether IN administration of analgesia is faster and leads to increased healthcare provider satisfaction compared to IV administration in patients with acute traumatic pain in a simulated military prehospital environment.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Robert P Weenink, PhD
- Phone Number: +31205669111
- Email: r.p.weenink@amsterdamumc.nl
Study Contact Backup
- Name: Midas N de Grunt, MD
- Phone Number: +31205669111
- Email: m.n.degrunt@amsterdamumc.nl
Study Locations
-
-
Noord-Holland
-
Amsterdam, Noord-Holland, Netherlands, 1105AZ
- Recruiting
- Amsterdam UMC
-
Contact:
- Midas N de Grunt, MD
- Phone Number: +31205669111
- Email: m.n.degrunt@amsterdamumc.nl
-
Principal Investigator:
- Markus W Hollmann, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- All navy nurses attending (simulation) training on prehospital trauma care.
Exclusion Criteria: none
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: IV first
Subjects in this group will be instructed to use intravenous administration in the first scenario and use intranasal administration in the second scenario.
|
Analgesia is administered intravenously.
Analgesia is administered intranasally using an atomizer.
|
Other: IN first
Subjects in this group will be instructed to use intranasal administration in the first scenario and use intravenous administration in the second scenario.
|
Analgesia is administered intravenously.
Analgesia is administered intranasally using an atomizer.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time required for administration of analgesic (minutes)
Time Frame: During simulation training (expected <5 minutes)
|
Time interval starts when healthcare provider grabs the first required item (e.g.
tourniquet, nasal atomizer, ampoule) from the medicine bag.
Time interval ends upon completed administration of analgesic.
|
During simulation training (expected <5 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total time spent on scene (minutes)
Time Frame: During simulation training (expected <10 minutes)
|
Time interval starts when healthcare provider arrives at the patient.
Time interval ends when analgesia has been administered and used materials have been disposed.
|
During simulation training (expected <10 minutes)
|
Time required for obtaining IV access
Time Frame: During simulation training (expected <5 minutes)
|
Time interval starts when healthcare provider grabs the first required item (e.g.
tourniquet or alcohol wipe) from the medicine bag.
Time interval ends when the IV catheter has been taped or flushed (whichever comes last).
|
During simulation training (expected <5 minutes)
|
Time required preparing IN administration
Time Frame: During simulation training (expected <0.5 minute)
|
Time interval starts when healthcare provider grabs the nasal atomizer.
Time interval ends when the nasal atomizer has been placed on the syringe.
|
During simulation training (expected <0.5 minute)
|
Satisfaction of the navy nurse regarding the used route of administration.
Time Frame: Directly after completion of simulation training
|
This is rated on a 0-10 Likert scale, where 0 represents "extremely unsatisfactory" and 10 represents "extremily satisfactory"
|
Directly after completion of simulation training
|
Collaborators and Investigators
Investigators
- Principal Investigator: Markus W Hollmann, PhD, Amsterdam UMC
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- INIV2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Analgesia
-
Mansoura UniversityNot yet recruiting
-
Southeast University, ChinaRecruiting
-
Medical University of South CarolinaRecruiting
-
Southeast University, ChinaRecruiting
-
Huazhong University of Science and TechnologyRecruiting
-
Mansoura UniversityCompleted
-
University of FloridaMdoloris Medical SystemsCompletedAnalgesiaUnited States
-
Mansoura UniversityCompleted
-
Cessatech A/SCompleted
-
Kalyra Pharmaceuticals, Inc.United States Department of Defense; PRA Health SciencesTerminated
Clinical Trials on Intravenous administration
-
Andalusian Initiative for Advanced Therapies -...Iniciativa Andaluza en Terapias AvanzadasCompletedAmyotrophic Lateral SclerosisSpain
-
Universitaire Ziekenhuizen KU LeuvenCompletedOvarian Cancer | Peritoneal MetastasisBelgium
-
Centre Hospitalier Universitaire, AmiensRecruitingFluid Therapy | Pharmacodynamics | Fluid Responsiveness | Fluid Challenge | Intravenous FluidsFrance
-
Toujinkai HospitalCompletedDisorder of Fatty Acid Metabolism
-
Hookipa Biotech GmbHRecruitingHPV-Related Squamous Cell CarcinomaUnited States, Spain, Netherlands
-
AkesoNot yet recruiting
-
Innervate Radiopharmaceuticals LLC (Formerly: Illumina...Icahn School of Medicine at Mount SinaiRecruitingCardiovascular DiseasesUnited States
-
Dartmouth-Hitchcock Medical CenterActive, not recruitingTrauma Injury | Bone InfectionUnited States
-
Dr. Lutfi Kirdar Kartal Training and Research HospitalNot yet recruiting
-
Seoul National University HospitalUnknown